Delayed and deferred surgery associated with cenobamate use in people with drug‐resistant focal epilepsy
Patients with drug-resistant focal epilepsy undergoing evaluation for epilepsy surgery may benefit from cenobamate. In this study, patients who received cenobamate during the presurgical evaluation were less likely to undergo surgery within 12 months. The delay to surgery identified among Hispanic and Latino patients suggests potential barriers to care in this patient population warranting further investigation.
Authors
- Stefan Sillau (ORCID: https://orcid.org/0000-0002-8691-3139)
- Louis Ferrari (ORCID: https://orcid.org/0000-0002-7060-6142)
- William E. Rosenfeld (ORCID: https://orcid.org/0000-0002-9504-3980)
- Jacob Pellinen (ORCID: https://orcid.org/0000-0002-0747-7210)
- Alexandra Danciutiu
- Christopher Elder
- Ashvin Sood
- Lesley Kaye
- Aimee Bui
Institutions
- Rocky Vista University (US)
- NYU Langone Health (US)
- Center for Children (US)
- SK Life Science (United States) (US)
- University of Wisconsin–Fond du Lac (US)
- New York University (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Epilepsia
- Published
- 2026-03-26
- DOI
- https://doi.org/10.1002/epi.70215
- Primary Topic
- Epilepsy research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00